
Genetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.

Genetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.

A Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.

Here are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.

As multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.

Widespread adoption of population-focused nursing practice will likely take place over the next five to 10 years. Here’s how to stay ahead of the curve.

Unique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.

Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.

Patients who lack resources likely won’t have improved health outcomes even with interventions. Some plans are exploring how to address the problem.

Education is a significant element of comprehensive care for COPD patients. In this Q&A, one expert shares her recommendations.

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.

While targeted cancer therapies make up a big part of the pipeline, there are three areas that oncology experts want you to keep on your radar.

Analysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.

New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.

Find out what worked for this value-based physician and hospital network and Accountable Care Organization in Massachusetts.

How can we as an industry help address the growing need and demand for quality mental health services? One of the more promising solutions is the expanded use of certified physician assistants.

Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.

An Epstein Becker Green survey has surprising results about the expansion of telehealth services physicians and other behavioral health professionals can provide.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

The success of any value-based care model depends on achieving a strong relationship with members. Here’s three ways how.

A new study has unbelievable findings about treating Medicare patients with diabetes.

A Robert Wood Johnson Foundation expert analyzes the Altarum Institute’s study on healthcare growth findings.

As genomics continues to evolve, here are five things to know about genetic testing and counseling.

A survey explores how physicians perceive their role in the healthcare system, and the findings aren’t good.